Stock Events

Acadia Pharmaceuticals (ACAD) Q2 2018 Earnings

4MayConfirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-0.72
-0.63
-0.53
-0.44

Details

Expected EPS
-0.55
Actual EPS
-0.44
Surprise EPS
0.11
Surprise Percent
+20%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.44 per share for Q2 2018.

0 Comments

Share your thoughts